Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Head and Neck Cancer

Free Subscription 21.08.2018 1 Am J Pathol 6 BMC Cancer 1 Clin Nucl Med 3 Dis Esophagus 1 Gastrointest Endosc 3 Head Neck 1 Int J Cancer 1 J Clin Oncol 1 J Oral Maxillofac Surg 16 Oral Oncol 1 Proc Natl Acad Sci U S A 1 Radiology 2 Surgery

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Pathol

1. NIKITSKI AV, Rominski SL, Wankhede M, Kelly LM, et al
   Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion.
   Am J Pathol. 2018 Aug 17. pii: S0002-9440(18)30415.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

2. MARIETTE C, Renaud F, Piessen G, Gele P, et al
   The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers.
   BMC Cancer. 2018;18:139.
   PubMed     Text format     Abstract available
   
   
3. PENSABENE M, Stanzione B, Cerillo I, Ciancia G, et al
   It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature.
   BMC Cancer. 2018;18:146.
   PubMed     Text format     Abstract available
   
   
4. NAMANI A, Matiur Rahaman M, Chen M, Tang X, et al
   Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
   BMC Cancer. 2018;18:46.
   PubMed     Text format     Abstract available
   
   
5. YOKOTA T, Serizawa M, Hosokawa A, Kusafuka K, et al
   PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
   BMC Cancer. 2018;18:826.
   PubMed     Text format     Abstract available
   
   
6. HARADA K, Ferdous T, Ueyama Y
   PD-L1 expression in malignant salivary gland tumors.
   BMC Cancer. 2018;18:156.
   PubMed     Text format     Abstract available
   
   
7. NOORDMAN BJ, Wijnhoven BPL, Lagarde SM, Boonstra JJ, et al
   Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial.
   BMC Cancer. 2018;18:142.
   PubMed     Text format     Abstract available
   
   

   
   Clin Nucl Med

8. TONG J, Jin Y, Liu M, Lv Z, et al
   False-Positive Uptake of 131I Due to Tubal Ligation in a Patient With Papillary Thyroid Cancer.
   Clin Nucl Med. 2018 Mar 7. doi: 10.1097/RLU.0000000000002055.
   PubMed     Text format     Abstract available
   
   

   
   Dis Esophagus

9. GRAHAM-WISENER L, Collins L, Hanna J, Dempster M, et al
   The need for enhanced psychological support in esophageal cancer-an exploratory study of the perception of HCPs, patients, and carers.
   Dis Esophagus. 2018 Aug 16. pii: 5075410. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
10. FUCHS HF, Schmidt HM, Meissner M, Brinkmann S, et al
    Endoscopic and histopathologic reflux-associated mucosal damage in the remnant esophagus following transthoracic esophagectomy for cancer-5-year long-term follow-up.
    Dis Esophagus. 2018;31:1-6.
    PubMed     Text format     Abstract available
    
    
11. BERKELMANS GHK, Fransen L, Weijs TJ, Lubbers M, et al
    The long-term effects of early oral feeding following minimal invasive esophagectomy.
    Dis Esophagus. 2018;31:1-8.
    PubMed     Text format     Abstract available
    
    

    
    Gastrointest Endosc

12. HORIE Y, Yoshio T, Aoyama K, Yoshimizu S, et al
    The diagnostic outcomes of esophageal cancer by artificial intelligence using convolutional neural networks.
    Gastrointest Endosc. 2018 Aug 15. pii: S0016-5107(18)32926.
    PubMed     Text format     Abstract available
    
    

    
    Head Neck

13. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25366.
    PubMed     Text format     Abstract available
    
    
14. DOMINGUES CSDC, Serambeque BP, Laranjo Candido MS, Marto CMM, et al
    Epithelial-mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer.
    Head Neck. 2018 Aug 18. doi: 10.1002/hed.25381.
    PubMed     Text format     Abstract available
    
    
15. KARATAS OF
    Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25361.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

16. MENYA D, Kigen N, Oduor M, Maina SK, et al
    Traditional and commercial alcohols and esophageal cancer risk in Kenya.
    Int J Cancer. 2018 Aug 17. doi: 10.1002/ijc.31804.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

17. JANJIGIAN YY, Bendell J, Calvo E, Kim JW, et al
    CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer.
    J Clin Oncol. 2018 Aug 15:JCO2017766212. doi: 10.1200/JCO.2017.76.6212.
    PubMed     Text format     Abstract available
    
    

    
    J Oral Maxillofac Surg

18. XU YM, Gong ZJ, Wu HJ
    Papillary Thyroid Carcinoma Incidentally Found in Cervical Lymph Nodes During Neck Dissection for Patients With Tongue Squamous Cell Carcinoma: A 3-Case Report and Literature Review.
    J Oral Maxillofac Surg. 2018 Jul 20. pii: S0278-2391(18)30833.
    PubMed     Text format     Abstract available
    
    

    
    Oral Oncol

19. WILKIE MD, Lau AS, Vlatkovic N, Jones TM, et al
    Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives.
    Oral Oncol. 2018;83:1-10.
    PubMed     Text format     Abstract available
    
    
20. ESKANDER A, Krzyzanowska MK, Fischer HD, Liu N, et al
    Emergency department visits and unplanned hospitalizations in the treatment period for head and neck cancer patients treated with curative intent: A population-based analysis.
    Oral Oncol. 2018;83:107-114.
    PubMed     Text format     Abstract available
    
    
21. HICKS DF, Bakst R, Doucette J, Kann BH, et al
    Impact of obesity on outcomes for patients with head and neck cancer.
    Oral Oncol. 2018;83:11-17.
    PubMed     Text format     Abstract available
    
    
22. MELISSANT HC, Jansen F, Schutte LER, Lissenberg-Witte BI, et al
    The course of sexual interest and enjoyment in head and neck cancer patients treated with primary (chemo)radiotherapy.
    Oral Oncol. 2018;83:120-126.
    PubMed     Text format     Abstract available
    
    
23. LECHNER M, Chakravarthy AR, Walter V, Masterson L, et al
    Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
    Oral Oncol. 2018;83:32-37.
    PubMed     Text format     Abstract available
    
    
24. CHOI N, Park SI, Kim H, Sohn I, et al
    The impact of unplanned reoperations in head and neck cancer surgery on survival.
    Oral Oncol. 2018;83:38-45.
    PubMed     Text format     Abstract available
    
    
25. PARK SY, Kim HI, Choi JY, Choe JH, et al
    Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles.
    Oral Oncol. 2018;84:41-45.
    PubMed     Text format     Abstract available
    
    
26. PENG LC, Hui X, Cheng Z, Bowers MR, et al
    Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.
    Oral Oncol. 2018;84:25-30.
    PubMed     Text format     Abstract available
    
    
27. FARQUHAR DR, Tanner AM, Masood MM, Patel SR, et al
    Oral tongue carcinoma among young patients: An analysis of risk factors and survival.
    Oral Oncol. 2018;84:7-11.
    PubMed     Text format     Abstract available
    
    
28. CHEN MM, Colevas AD, Megwalu U, Divi V, et al
    Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Oral Oncol. 2018;84:71-75.
    PubMed     Text format     Abstract available
    
    
29. DRONKERS EAC, Hoesseini A, de Boer MF, Offerman MPJ, et al
    Communication of prognosis in head and neck cancer patients; a descriptive qualitative analysis.
    Oral Oncol. 2018;84:76-81.
    PubMed     Text format     Abstract available
    
    
30. STOKES WA, Eguchi M, Amini A, Hararah MK, et al
    Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
    Oral Oncol. 2018;84:12-19.
    PubMed     Text format     Abstract available
    
    
31. LALA M, Chirovsky D, Cheng JD, Mayawala K, et al
    Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review.
    Oral Oncol. 2018;84:108-120.
    PubMed     Text format     Abstract available
    
    
32. LI Y, Xu T, Qian W, Lu X, et al
    Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
    Oral Oncol. 2018;84:1-6.
    PubMed     Text format     Abstract available
    
    
33. PATTERSON JM, McColl E, Carding PN, Wilson JA, et al
    Swallowing beyond six years post (chemo)radiotherapy for head and neck cancer; a cohort study.
    Oral Oncol. 2018;83:53-58.
    PubMed     Text format     Abstract available
    
    
34. WEISS J, Gilbert J, Deal AM, Weissler M, et al
    Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck.
    Oral Oncol. 2018;84:46-51.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

35. LIU Y, Liu Y, Wu J, Roizman B, et al
    Innate responses to gene knockouts impact overlapping gene networks and vary with respect to resistance to viral infection.
    Proc Natl Acad Sci U S A. 2018;115:E3230-E3237.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

36. TESSLER FN, Middleton WD, Grant EG, Hoang JK, et al
    Guidelines for Biopsy of Thyroid Nodules.
    Radiology. 2018;288:635-636.
    PubMed     Text format    
    
    

    
    Surgery

37. YOUNGWIRTH LM, Adam MA, Thomas SM, Roman SA, et al
    Pediatric thyroid cancer patients referred to high-volume facilities have improved short-term outcomes.
    Surgery. 2017 Nov 22. pii: S0039-6060(17)30689.
    PubMed     Text format     Abstract available
    
    
38. DELONG JC, Ward EP, Lwin TM, Brumund KT, et al
    Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism.
    Surgery. 2018;163:388-392.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: